Abstract:Abstract Background and aims: Inflammatory microenvironment plays a critical role in promoting hepatocellular carcinoma (HCC) progression. Among the factors secreted by cancer-associated inflammatory cells, tumor necrosis factor-alpha (TNF-α) has been identified as a master regulator of inflammation and a potential mediator in inflammation-related cancers. Forkhead box M1 (FoxM1) is a key cell cycle regulator of the transition from the G1 to the S phase and the progression to mitosis. We previously reported that FoxM1 promotes metastasis and indicates poor prognosis in HCC. However, the critical regulatory mechanism linking TNF-α to FoxM1 activation in inflammation-induced HCC progression remains unclear. In this study, we aim to investigate the mechanism by which FoxM1 is regulated by TNF-α, and the potential role of FoxM1 in inflammation-associated HCC. Methods: Luciferase reporter, chromatin immunoprecipitation, and electrophoretic mobility shift assays were used to measure the transcriptional regulation of FoxM1 promoter by TNF-α. The clinical significance of TNF-α/ROS/HIF-1/FoxM1 pathway in a cohort of 406 HCC patients who underwent curative resection was assessed by Kaplan-Meier analysis and Multivariate Cox proportional hazards model. Results: TNF-α induced FoxM1 expression and transactivated its promoter activity in hepatoma cells. Serial 5′ deletion and site-directed mutagenesis revealed that the induction of FoxM1 expression by TNF-α was dependent upon the HIF1-1 and HIF1-3/4 binding sites within the FoxM1 promoter. Furthermore, at the transcriptional level, the stabilization of HIF-1α via reactive oxygen species (ROS) generation led to the binding of HIF-1α to the FoxM1 promoter and resulted in increased FoxM1 expression. The inhibition of both HIF-1α expression and ROS generation significantly decreased TNF-α-induced FoxM1 expression. Consequently, the upregulation of FoxM1 promoted the proliferation of hepatoma cells and enhanced their resistance to TNF-α-induced apoptosis, whereas downregulation of FoxM1 dramatically attenuated these effects. TNF-α expression was positively correlated with HIF-1α and FoxM1 expression in human HCC tissues. Patients with positive coexpression of TNF-α and FoxM1 had shorter overall survival and higher recurrence rates than those with negative coexpression of TNF-α and FoxM1. Simarily, patients with HIF-1(+)/FoxM1(+) expression had shorter overall survival and higher recurrence rates than those with HIF-1(-)/FoxM1(-) expression. Conclusions: We report a new molecular mechanism by which FoxM1 expression is regulated by the TNF-α/ROS/HIF-1 pathway, and this mechanism results in the proliferation of hepatoma cells and their resistance to apoptosis. Thus, TNF-α/ROS/HIF-1/FoxM1 pathway may provide a target for clinical intervention in HCC. Citation Format: Limin Xia, Daiming Fan, Yongzhan Nie, Kaichun Wu. The TNF-α/ROS/HIF-1-mediated upregulation of FoxM1 expression promotes proliferation, resistance to apoptosis and indicates poor prognosis in hepatocellular carcinoma. [abstract]. In: Proceedings of the 104th Annual Meeting of the American Association for Cancer Research; 2013 Apr 6-10; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2013;73(8 Suppl):Abstract nr 2862. doi:10.1158/1538-7445.AM2013-2862 Note: This abstract was not presented at the AACR Annual Meeting 2013 because the presenter was unable to attend.

Elevated expression of FoxM1 promotes the tumor cell proliferation in hepatocellular carcinoma

FOXM1 Promotes Proliferation in Human Hepatocellular Carcinoma Cells by Transcriptional Activation of CCNB1.

Overexpression of Forkhead Box M1 Protein Associates with Aggressive Tumor Features and Poor Prognosis of Hepatocellular Carcinoma

The TNF-α/ROS/HIF-1-induced upregulation of FoxMI expression promotes HCC proliferation and resistance to apoptosis.

FOXM1 promotes hepatocellular carcinoma progression by regulating KIF4A expression

The critical role of dysregulated Hh-FOXM1-TPX2 signaling in human hepatocellular carcinoma cell proliferation

Foxm1 Overexpression Promotes Epithelial-Mesenchymal Transition and Metastasis of Hepatocellular Carcinoma

Retraction Note: Forkhead Box (FOX) G1 Promotes Hepatocellular Carcinoma Epithelial-Mesenchymal Transition by Activating Wnt Signal Through Forming T-cell Factor-4/Beta-catenin/foxg1 Complex

Decreased FOXF1 Promotes Hepatocellular Carcinoma Tumorigenesis, Invasion, and Stemness and is Associated with Poor Clinical Outcome.

Forkhead Box S1 Inhibits the Progression of Hepatocellular Carcinoma

Transcription Factor FOXM1 Promotes Hepatocellular Carcinoma Malignant Progression Through Activation of the WNT Pathway by Binding to SETDB1.

Abstract 2862: The TNF-α/ROS/HIF-1-mediated upregulation of FoxM1 expression promotes proliferation, resistance to apoptosis and indicates poor prognosis in hepatocellular carcinoma.

Overexpression of forkhead box C1 promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma.

Overexpression of FoxM1 is Associated with Tumor Progression in Patients with Clear Cell Renal Cell Carcinoma

FOXM1-induced TYMS upregulation promotes the progression of hepatocellular carcinoma

Downregulation of FOXP1 Inhibits Cell Proliferation in Hepatocellular Carcinoma by Inducing G1/S Phase Cell Cycle Arrest.

Aberrantly high activation of a FoxM1–STMN1 axis contributes to progression and tumorigenesis in FoxM1-driven cancers

Overexpression of FoxM1 predicts poor prognosis of intrahepatic cholangiocarcinoma.

FOXR2 Contributes to Cell Proliferation and Malignancy in Human Hepatocellular Carcinoma

Nuclear accumulation of glioma-associated oncogene 2 protein and enhanced expression of forkhead-box transcription factor M1 protein in human hepatocellular carcinoma.

Prognostic Significance of Foxp1 As an Oncogene in Hepatocellular Carcinoma